MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$63,635K
EPS
-$0.22
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
30,729
28,719
42,180*
30,106
Research and development related success payments and contingent consideration
23,913
8,433
9,353*
3,124
General and administrative
10,778
11,462
13,357*
10,285
Impairment of long-lived assets
0
-
-22,305*
-
Total operating expenses
65,420
48,614
42,584
43,515
Loss from operations
-65,420
-48,614
-42,584*
-43,515
Interest income, net
1,129
951
1,478*
1,003
Other income, net
656
453
868*
360
Net loss
-63,635
-47,210
-40,238
-42,152
Basic EPS
-0.22
-0.17
-0.154
-0.16
Diluted EPS
-0.22
-0.17
-0.154
-0.16
Basic Average Shares
295,667,000
276,856,000
260,799,000
260,494,000
Diluted Average Shares
295,667,000
276,856,000
260,799,000
260,494,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$63,635K
(32.16%↑ Y/Y)
Interest income, net
$1,129K
(95.67%↑ Y/Y)
Other income, net
$656K
(9.70%↑ Y/Y)
Loss from operations
-$65,420K
(31.12%↑ Y/Y)
Total operating
expenses
$65,420K
(-31.12%↓ Y/Y)
Research and development
$30,729K
(3.25%↑ Y/Y)
Research and development
related success...
$23,913K
(133.02%↑ Y/Y)
General and
administrative
$10,778K
(4.23%↑ Y/Y)
Buy us a coffee
Sana Biotechnology, Inc. (SANA)
Sana Biotechnology, Inc. (SANA)